GO
Loading...

Eli Lilly and Co

More

  • Final Glance: Pharmaceuticals companies Friday, 30 Jan 2015 | 6:02 PM ET

    Baxter International Inc. fell $1.07 or 1.5 percent, to $70.31. Bristol-Myers Squibb Co. fell$. 87 or 1.4 percent, to $60.27. Hospira fell $1.35 or 2.1 percent, to $63.43.

  • Midday Glance: Pharmaceuticals companies Friday, 30 Jan 2015 | 1:27 PM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $71.45. Bristol-Myers Squibb Co. fell$. 27 or. 4 percent, to $60.87. Hospira fell$. 62 or 1.0 percent, to $64.16.

  • Early Glance: Pharmaceuticals companies Friday, 30 Jan 2015 | 11:13 AM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $71.55. Bristol-Myers Squibb Co. fell$. 54 or. 9 percent, to $60.60. Hospira fell $1.05 or 1.6 percent, to $63.73.

  • Jan 30- Eli Lilly and Co cut its 2015 revenue forecast, issued earlier this month, as the U.S. drugmaker expects a bigger hit from a stronger dollar. Large U.S. healthcare companies such as Johnson& Johnson, Pfizer Inc and Bristol-Myers Squibb Co have in the past weeks issued 2015 earnings forecasts below Wall Street expectations, citing the stronger dollar.

  • Lilly beats Street 4Q forecasts Friday, 30 Jan 2015 | 6:48 AM ET

    INDIANAPOLIS _ Eli Lilly and Co. on Friday reported fourth-quarter profit of $428.5 million. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of 74 cents per share. Analysts expected $5.11 billion, according to Zacks.

  • Jan 30- U.S. drugmaker Eli Lilly and Co reported a 41 percent fall in quarterly profit, hurt by a stronger dollar and a one-time charge related to a restructuring program. The U.S. drugmaker said it earned $428.5 million, or 40 cents per share, in the fourth quarter ended Dec. 31 from $727.5 million, or 67 cents per share, a year earlier. The company's earnings have been...

  • Final Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 6:14 PM ET

    Baxter International Inc. rose $1.22 or 1.7 percent, to $71.38. Bristol-Myers Squibb Co. fell$. 19 or. 3 percent, to $61.14. Hospira rose$. 13 or. 2 percent, to $64.78.

  • Midday Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 1:23 PM ET

    Baxter International Inc. rose$. 68 or 1.0 percent, to $70.84. Bristol-Myers Squibb Co. fell$. 62 or 1.0 percent, to $60.72. Hospira fell$. 68 or 1.1 percent, to $63.97.

  • Early Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 10:40 AM ET

    Baxter International Inc. rose$. 57 or. 8 percent, to $70.73. Bristol-Myers Squibb Co. fell$. 77 or 1.3 percent, to $60.56. Hospira fell$. 49 or. 8 percent, to $64.16.

  • Final Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 6:07 PM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $70.16. Bristol-Myers Squibb Co. fell$. 66 or 1.1 percent, to $61.33. Hospira fell$. 84 or 1.3 percent, to $64.65.

  • Midday Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 1:21 PM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $70.83. Bristol-Myers Squibb Co. rose$. 48 or. 8 percent, to $62.47. Hospira fell$. 21 or. 3 percent, to $65.28.

  • Early Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 10:41 AM ET

    Baxter International Inc. rose$. 27 or. 4 percent, to $70.93. Bristol-Myers Squibb Co. rose$. 66 or 1.1 percent, to $62.65. Hospira rose$. 30 or. 5 percent, to $65.79.

  • Final Glance: Pharmaceuticals companies Tuesday, 27 Jan 2015 | 6:08 PM ET

    Baxter International Inc. fell$. 22 or. 3 percent, to $70.66. Bristol-Myers Squibb Co. fell$. 47 or. 8 percent, to $61.99. Hospira fell $1.01 or 1.5 percent, to $65.49.

  • Midday Glance: Pharmaceuticals companies Tuesday, 27 Jan 2015 | 1:36 PM ET

    Baxter International Inc. fell$. 10 or. 1 percent, to $70.78. Bristol-Myers Squibb Co. fell$. 61 or 1.0 percent, to $61.85. Hospira fell$. 69 or 1.0 percent, to $65.81.

  • Early Glance: Pharmaceuticals companies Tuesday, 27 Jan 2015 | 10:25 AM ET

    Baxter International Inc. fell$. 27 or. 4 percent, to $70.61. Bristol-Myers Squibb Co. fell$. 81 or 1.3 percent, to $61.65. Hospira fell$. 44 or. 7 percent, to $66.06.

  • Final Glance: Pharmaceuticals companies Monday, 26 Jan 2015 | 6:04 PM ET

    Baxter International Inc. fell$. 55 or. 8 percent, to $70.88. Bristol-Myers Squibb Co. rose$. 39 or. 6 percent, to $62.46. Hospira rose $1.11 or 1.7 percent, to $66.50.

  • Midday Glance: Pharmaceuticals companies Monday, 26 Jan 2015 | 1:53 PM ET

    Baxter International Inc. fell$. 59 or. 8 percent, to $70.84. Bristol-Myers Squibb Co. rose$. 45 or. 7 percent, to $62.52. Hospira rose$. 42 or. 6 percent, to $65.81.

  • Early Glance: Pharmaceuticals companies Monday, 26 Jan 2015 | 12:16 PM ET

    Baxter International Inc. fell$. 58 or. 8 percent, to $70.85. Bristol-Myers Squibb Co. rose$. 06 or. 1 percent, to $62.13. Hospira fell$. 81 or 1.2 percent, to $64.58.

  • NEW YORK, Jan 26- A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells are proving to be immensely effective weapons against tumors, potentially transforming the $100 billion global market for drugs that fight the disease. But top oncology researchers are concerned about the two emerging technologies, citing...

  • Final Glance: Pharmaceuticals companies Friday, 23 Jan 2015 | 6:04 PM ET

    Baxter International Inc. fell$. 83 or 1.1 percent, to $71.43. Bristol-Myers Squibb Co. fell$. 02 or percent, to $62.07. Hospira rose$. 65 or 1.0 percent, to $65.39.